Comorbidity in limited disease small-cell lung cancer: Age-adjusted Charlson comorbidity index and its association with overall survival following chemoradiotherapy

Comorbidity in limited disease small-cell lung cancer: Age-adjusted Charlson comorbidity index and its association with overall survival following chemoradiotherapy

Background: Combined, platinum-based thoracic chemoradiotherapy (TCR) is the current state-of-the-art treatment for patients with limited disease (LD) small-cell lung cancer (SCLC). There is only limited data available regarding the effect of comorbidities on survival following TRC. The purpose of t...

Full description

Bibliographic Details
Main Authors: Christoph A. Fink, Fabian Weykamp, Sebastian Adeberg, Farastuk Bozorgmehr, Petros Christopoulos, Kristin Lang, Laila König, Juliane Hörner-Rieber, Michael Thomas, Martin Steins, Rami A. El-Shafie, Stefan Rieken, Denise Bernhardt, Jürgen Debus
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Clinical and Translational Radiation Oncology
Subjects:
Small cell lung cancer
Survival
Limited disease
Comorbidity
Charlson comorbidity index
CCI
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630823000903

Internet

http://www.sciencedirect.com/science/article/pii/S2405630823000903

Similar Items